InvestorsHub Logo
Followers 62
Posts 7582
Boards Moderated 1
Alias Born 01/02/2003

Re: Birdbrain Ideas post# 385722

Tuesday, 08/09/2022 3:22:03 PM

Tuesday, August 09, 2022 3:22:03 PM

Post# of 427309
Amarin should pursue this case, which is hurting Vascepa through infringement on their CVD patents..which insurance companies, pharmacies, and the courts (and even the congress) realize is happening but no one wants to admit it is happening or do anything to correct it.

In the meantime, drug innovation is being stifled...Amarin would be actively pursuing additional indications for Vascepa, if not for this injustice, and American patients are the biggest losers.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News